02 Frequency Many patients receive these injections once weekly to maintain consistent metabolic and energy support
Performed the experiments: NL JL
With the current line-up of GLP-1s, you have to keep taking the medication into perpetuity for it to have the desired effect
Emerging evidence from clinical trials and observational research showing the additive benefits of combining SGLT2i and GLP-1RA, including evidence from the present study, suggests that the addition of GLP-1RA can provide further metabolic and cardiorenal risk reductions in those who are not achieving treatment goals with SGLT2i alone
For patients who want the stronger evidence base and convenience of weekly treatment, learning proper injection technique may be worthwhile
Many practitioners recommend starting with a series of treatments performed weekly or bi-weekly, followed by maintenance sessions once every month or two, depending on the results desired